Bugworks Research Inc welcomes Dr. Renu Swarup to its Global Advisory Board
PR99601
BANGALORE, India, SARATOGA, Calif. and ADELAIDE, Australia, Feb. 22, 2023 /PRNewswire=KYODO JBN/ --
Former secretary of the Department of Biotechnology, Government of India
and reputed Biotechnologist joins the Advisory Board to provide strategic
guidance to the project portfolio of Bugworks Research
Bugworks Research, a clinical-stage biopharmaceutical company, has engaged
Dr. Renu Swarup as a honorary member of the Global Advisory Board. Dr. Swarup
is the former Secretary, Department of Biotechnology, Government of India and
brings in more than three decades of experience in the biotech sector.
As the Member Secretary of the Expert Committee, Dr. Swarup oversaw the
formulation of Biotechnology Vision in 2001, National Biotechnology Development
Strategy in 2007 and Strategy II, 2015-20. She was the Founding Managing
Director, Biotechnology Industry Research Assistance Council (BIRAC), a Public
Sector Company with special focus on supporting Start-ups and SMEs. By
strengthening biotechnology translational research and industry-academia
partnerships, she has supported more than 5000 Start-ups and nearly 500 small
companies to pursue innovative research and product development. She is a
fellow of the National Academy of Sciences, India (NASI). She has actively
supported women scientists as a member of the Prime Minister's Scientific
Advisory Committee's task force on women in science and is part of The
Organization for Women in Science for the Developing World. She played a
critical role in DBT's response to create technological solutions to tackle
COVID-19 in India.
Speaking on her appointment, Dr. Anand Anandkumar - CEO, Bugworks Research
states, "Bugworks is pleased to welcome Dr. Renu Swarup as a member of its
Global Advisory Board. Dr. Swarup, an accomplished geneticist, was formerly the
Secretary, Department of Biotechnology, Ministry of Science & Technology,
India. She was one of the key architects to formulate India's Biotechnology
Vision and Strategy including the COVID-19 vaccine roll-out initiatives. Under
her inspirational leadership, Biotechnology Industry Research Assistance
Council (BIRAC) has ushered in a new wave of biotech SMEs and start-ups, of
which Bugworks was an early benefactor. We look forward to working closely with
Dr. Swarup to help us reach our goal of enabling equitable global access to
Bugworks' innovative products."
On joining Bugworks Research, Dr. Renu Swarup said, "I am pleased to be
associated with Bugworks in my capacity as an Honorary Advisor and member of
their Global Advisory Board. The vision of Bugworks on combating critical unmet
health priorities of AMR and cancer is of global importance. Their work on new
broad-spectrum antibiotics and novel immuno-oncologic small molecules targeting
several solid cell tumors, to make these affordable and accessible to humanity,
is of special significance. The company occupies a niche area in their effort
to enable patients especially from LMICs to gain access to cutting-edge
therapies in infection and cancer."
About Bugworks
Bugworks Research Inc, (Bugworks), is a clinical stage biopharmaceutical
company founded in February 2014, that is developing novel therapeutic assets
in the anti-infectives and immuno-oncology (IO) areas using innovative science
from the frontiers of computational biology, pharmacology, structural-biology,
and medicinal chemistry. BWC0977 is currently in a Phase 1 clinical trial and
is targeted to address unmet needs of serious hospital & community infections,
and bacterial biothreats. Its asset for IO is in the late pre-clinical stage,
targets multiple cancers and is expected to be used either standalone or in
combination with immune checkpoint therapies.
For further information, please visit www.bugworksresearch.com
Media Contact Information :
Concept Public Relations
Archana Jain, archana@conceptindia.com, +91 98455 41244
Aditi Nair, Aditi@conceptpr.com, +91 9071949810
Photo: https://mma.prnewswire.com/media/2007532/Renu_Swarup_photo.jpg
Logo: https://mma.prnewswire.com/media/1491889/Bugworks_Logo.jpg
Source: Bugworks
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。